다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
USOTC
Elite Pharmaceuticals Inc (QB) (ELTP)
Elite Pharmaceuticals Inc (QB) (ELTP) 뉴스

ELTP

Elite Pharmaceuticals (QB) (ELTP)

Elite Pharmaceuticals Inc (QB)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:ELTP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/21	05:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2024/02/15	06:55	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/12/30	04:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/12/27	06:20	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/12/13	06:20	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/11/28	09:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/11/28	08:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/11/28	08:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/11/16	21:32	InvestorsHub NewsWire	Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/09/26	05:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/09/08	05:05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/08/15	06:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/08/01	05:20	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/07/18	05:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/06/30	06:15	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/06/30	06:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/06/30	05:44	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/06/30	05:43	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/06/27	01:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/05/04	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/04/20	23:06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/03/01	06:42	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/02/15	07:30	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2023/02/15	06:29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2022/11/15	06:54	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2022/11/11	06:19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2022/11/03	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2022/09/08	05:36	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2022/08/30	02:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)
2022/08/30	02:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ELTP	Elite Pharmaceuticals Inc (QB)

검색 관련기사 보기:USOTC:ELTP

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan Chase

VanadiumCorp Resource (PK)

Caisse Depots et Consign...

Vontobel Financial Produ...

Brookfield Property Part...

Societe Generale Effekten

Cohen and Steers Global ...

ABEVT217 Ex:21,73

Annaly Capital Management, Inc.

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관